Non-invasive assessment for endothelial CD81 expression via targeted microbubbles.

Area of Science:

• Biomedical Engineering
• Molecular Imaging
• Cell Biology

Background:

• Endothelial CD81 expression is a potential biomarker in vascular diseases.
• Molecular ultrasound imaging offers non-invasive assessment capabilities.
• Targeted microbubbles enhance imaging specificity.

Purpose of the Study:

• To develop and evaluate CD81-targeted ultrasound microbubbles (MBs) for molecular imaging.
• To assess CD81 expression changes in murine endothelial cells.
• To explore the potential for early atherosclerotic plaque detection.

Main Methods:

• Preparation and characterization of anti-CD81-coated MBs.
• Stimulation of murine bEnd.3 cells with phenazine methosulfate (PMS) to up-regulate CD81.
• Imaging of CD81 expression using a SONIX RP ultrasound system.

Main Results:

• CD81 expression increased with PMS concentration.
• Accumulation of targeted MBs correlated with CD81 expression.
• Targeted MB accumulation was competitively inhibited.
• Significantly higher video intensity in stimulated vs. non-stimulated cells (17.5 ± 3.6 vs. 12.1 ± 2.9 pixel intensity; P < 0.01).

Conclusions:

• CD81-targeted MBs enable non-invasive assessment of CD81 expression on endothelial cells.
• This method holds potential for early atherosclerotic plaque detection.
• It may also aid in monitoring treatment efficacy using molecular ultrasound imaging.